WHO, Germany open hub for pandemic and epidemic intelligence in Berlin

New hub’s mission is to provide the world with better data, analytics and decisions to detect and respond to health emergencies

3 Min
More

Cancer cells on the wrong path – How adaptations can make cancer treatment more difficult

Each tumor consists of multiple cell types, all of which have distinct characteristics. In addition to determining the course of the disease, these differences between individual cancer cells control the effectiveness of targeted therapies. A team of…

3 Min
More

atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update

 

-Successfully completed Initial Public Offering on Nasdaq raising $258.8 million in gross proceeds, including the underwriters’ over-allotment-

-Received $20 million upfront payment from Otsuka as part of the first major collaboration between a…

12 Min
More

Cystic Fibrosis – Increasing numbers of patients benefit from improved treatment

A clinical trial, conducted by an international team of researchers and co-led by Charité – Universitätsmedizin Berlin, has shown that a triple combination therapy consisting of three known compounds is both safe and effective in cystic fibrosis…

6 Min
More

Nobelpharma signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX®

 

ProBioGen is pleased to announce that Nobelpharma has signed a license agreement for the use of the AGE1.CR.pIX vaccine production platform to develop their lead vaccine. The signing of the agreement is yet another milestone in a series of fruitful…

1 Min
More

Interview with Björn von Siemens, Co-Founder of caresyntax

Björn von Siemens is co-founder and managing director of caresyntax GmbH. The company develops algorithms that analyze risk factors during surgery and provide decision support. The company, based in Berlin and Boston, recently raised 100 million US…

3 Min
More

Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials

 

– Seventure Partners and Novartis Pharmaceuticals join as new investors

– Transformative treatment for millions of children with myopia

Berlin, Germany, July 14, 2021 — Dopavision, a company pioneering the development of digital therapeutics,…

7 Min
More

City of Hope takes a Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

 

Berlin, Germany and Duarte, USA, June 9, 2021:

ProBioGen AG has announced a commercial product license agreement with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening…

3 Min
More
Show more items